Amphastar Pharmaceuticals (AMPH) Inventory (2013 - 2026)

Amphastar Pharmaceuticals' Inventory history runs 14 years deep, the most recent figure standing at $170.2 million for Q1 2026.

• In Q1 2026, Inventory fell 8.24% year-over-year to $170.2 million; the TTM figure through Mar 2026 stood at $170.2 million (down 8.24% YoY), while the FY2025 annual figure was $176.9 million, up 15.06% from the prior year.
• Inventory was $170.2 million for Q1 2026 at Amphastar Pharmaceuticals, down from $176.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $191.7 million in Q2 2025 to a low of $95.1 million in Q1 2022.
• Historically, Inventory has averaged $132.8 million across 5 years, with a median of $115.5 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Inventory soared 60.59% in 2025, then retreated 8.24% in 2026.
• A 5-year view of Inventory shows it stood at $103.6 million in 2022, then gained by 2.17% to $105.8 million in 2023, then soared by 45.27% to $153.7 million in 2024, then increased by 15.06% to $176.9 million in 2025, then slipped by 3.79% to $170.2 million in 2026.
• The last three Inventory figures came in at $170.2 million (Q1 2026), $176.9 million (Q4 2025), and $185.9 million (Q3 2025), per Business Quant data.